Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
GRAND RAPIDS, Mich., Sept. 1, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management...
Covered in this story
What has happened since
- Morgan Stanley is down 14.5% since this was published, 49 days ago.
- Shoulder Innovations Inc is down 8.9% since this was published, 49 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Morgan Stanley
- Morgan Stanley: $216 → $215 by Jul 2027 via GuruFocus
- RBC Capital Markets: $211 → $243 by Jul 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Morgan Stanley →Dalsna Finance is currently tracking 55 stories mentioning Morgan Stanley, the earliest published 15 Apr 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.